Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease

The objective of the present study was define in a relatively large patient population with coronary artery disease (CAD) whether the concomitant presence of peripheral artery disease (PAD), which is known to convey additional cardiovascular risk, was associated with different circulating levels of...

Full description

Saved in:
Bibliographic Details
Main Authors: Colomba Falcone, Sara Bozzini, Luigina Guasti, Angela D’Angelo, Anna Clizia Capettini, Edoardo Maria Paganini, Rossana Falcone, Roberto Moia, Carmine Gazzaruso, Gabriele Pelissero
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2013/584504
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561246524669952
author Colomba Falcone
Sara Bozzini
Luigina Guasti
Angela D’Angelo
Anna Clizia Capettini
Edoardo Maria Paganini
Rossana Falcone
Roberto Moia
Carmine Gazzaruso
Gabriele Pelissero
author_facet Colomba Falcone
Sara Bozzini
Luigina Guasti
Angela D’Angelo
Anna Clizia Capettini
Edoardo Maria Paganini
Rossana Falcone
Roberto Moia
Carmine Gazzaruso
Gabriele Pelissero
author_sort Colomba Falcone
collection DOAJ
description The objective of the present study was define in a relatively large patient population with coronary artery disease (CAD) whether the concomitant presence of peripheral artery disease (PAD), which is known to convey additional cardiovascular risk, was associated with different circulating levels of sRAGE with respect to CAD alone and control subjects. Clinical and laboratory parameters including the ankle brachial index (ABI) and sRAGE (enzyme-linked immunosorbent assay kit) were investigated in 544 patients with angiographically documented CAD and 328 control subjects. 213/554 CAD patients (39%) showed an ABI <0.9 associated with typical symptoms (group CAD + PAD), whereas 331 patients were free from PAD. The concentration of plasma sRAGE was significantly lower (P<0.0001) in CAD population, with and without PAD, than in control subjects. Among CAD patients, those with PAD showed lower levels of sRAGE. The distribution of the three groups (CAD, CAD + PAD, and controls) according to sRAGE tertiles showed that lower levels were more frequent in patients with CAD and CAD + PAD, whereas higher levels were more frequently found in controls. CAD patients presenting with PAD have lower sRAGE levels than CAD patients without peripheral atherosclerosis showing that stable atherosclerotic lesions in different vascular districts are inversely related to soluble decoy receptor sRAGE.
format Article
id doaj-art-cd36e8a060f0449aa78c5a0d1b470e26
institution Kabale University
issn 1537-744X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-cd36e8a060f0449aa78c5a0d1b470e262025-02-03T01:25:32ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/584504584504Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery DiseaseColomba Falcone0Sara Bozzini1Luigina Guasti2Angela D’Angelo3Anna Clizia Capettini4Edoardo Maria Paganini5Rossana Falcone6Roberto Moia7Carmine Gazzaruso8Gabriele Pelissero9Interdepartmental Center of Research in Molecular Medicine (CIRMC), University of Pavia, 27100 Pavia, ItalyInterdepartmental Center of Research in Molecular Medicine (CIRMC), University of Pavia, 27100 Pavia, ItalyDepartment of Clinical and Experimental Medicine, University of Insubria, 21100 Varese, ItalyDepartment of Internal Medicine, IRCCS Policlinico San Matteo, 27100 Pavia, ItalyInterdepartmental Center of Research in Molecular Medicine (CIRMC), University of Pavia, 27100 Pavia, ItalyDepartment of Cardiology, “Istituti Clinici di Pavia e Vigevano” University Hospital, 27100 Pavia, ItalyInterdepartmental Center of Research in Molecular Medicine (CIRMC), University of Pavia, 27100 Pavia, ItalyInterdepartmental Center of Research in Molecular Medicine (CIRMC), University of Pavia, 27100 Pavia, ItalyInterdepartmental Center of Research in Molecular Medicine (CIRMC), University of Pavia, 27100 Pavia, ItalyDepartment of Cardiology, “Istituti Clinici di Pavia e Vigevano” University Hospital, 27100 Pavia, ItalyThe objective of the present study was define in a relatively large patient population with coronary artery disease (CAD) whether the concomitant presence of peripheral artery disease (PAD), which is known to convey additional cardiovascular risk, was associated with different circulating levels of sRAGE with respect to CAD alone and control subjects. Clinical and laboratory parameters including the ankle brachial index (ABI) and sRAGE (enzyme-linked immunosorbent assay kit) were investigated in 544 patients with angiographically documented CAD and 328 control subjects. 213/554 CAD patients (39%) showed an ABI <0.9 associated with typical symptoms (group CAD + PAD), whereas 331 patients were free from PAD. The concentration of plasma sRAGE was significantly lower (P<0.0001) in CAD population, with and without PAD, than in control subjects. Among CAD patients, those with PAD showed lower levels of sRAGE. The distribution of the three groups (CAD, CAD + PAD, and controls) according to sRAGE tertiles showed that lower levels were more frequent in patients with CAD and CAD + PAD, whereas higher levels were more frequently found in controls. CAD patients presenting with PAD have lower sRAGE levels than CAD patients without peripheral atherosclerosis showing that stable atherosclerotic lesions in different vascular districts are inversely related to soluble decoy receptor sRAGE.http://dx.doi.org/10.1155/2013/584504
spellingShingle Colomba Falcone
Sara Bozzini
Luigina Guasti
Angela D’Angelo
Anna Clizia Capettini
Edoardo Maria Paganini
Rossana Falcone
Roberto Moia
Carmine Gazzaruso
Gabriele Pelissero
Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
The Scientific World Journal
title Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
title_full Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
title_fullStr Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
title_full_unstemmed Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
title_short Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
title_sort soluble rage plasma levels in patients with coronary artery disease and peripheral artery disease
url http://dx.doi.org/10.1155/2013/584504
work_keys_str_mv AT colombafalcone solublerageplasmalevelsinpatientswithcoronaryarterydiseaseandperipheralarterydisease
AT sarabozzini solublerageplasmalevelsinpatientswithcoronaryarterydiseaseandperipheralarterydisease
AT luiginaguasti solublerageplasmalevelsinpatientswithcoronaryarterydiseaseandperipheralarterydisease
AT angeladangelo solublerageplasmalevelsinpatientswithcoronaryarterydiseaseandperipheralarterydisease
AT annacliziacapettini solublerageplasmalevelsinpatientswithcoronaryarterydiseaseandperipheralarterydisease
AT edoardomariapaganini solublerageplasmalevelsinpatientswithcoronaryarterydiseaseandperipheralarterydisease
AT rossanafalcone solublerageplasmalevelsinpatientswithcoronaryarterydiseaseandperipheralarterydisease
AT robertomoia solublerageplasmalevelsinpatientswithcoronaryarterydiseaseandperipheralarterydisease
AT carminegazzaruso solublerageplasmalevelsinpatientswithcoronaryarterydiseaseandperipheralarterydisease
AT gabrielepelissero solublerageplasmalevelsinpatientswithcoronaryarterydiseaseandperipheralarterydisease